Decreased Hypothalamic Glucagon-Like Peptide-1 Receptor Expression in Type 2 Diabetes Patients.

@article{Kulve2016DecreasedHG,
  title={Decreased Hypothalamic Glucagon-Like Peptide-1 Receptor Expression in Type 2 Diabetes Patients.},
  author={Jennifer S Ten Kulve and L van Bloemendaal and Rawien A Balesar and Richard G. Ijzerman and Dick F. Swaab and Michaela Diamant and Susanne E la Fleur and Anneke Alkemade},
  journal={The Journal of clinical endocrinology and metabolism},
  year={2016},
  volume={101 5},
  pages={2122-9}
}
CONTEXT Glucagon-like peptide-1 (GLP-1) and GLP-1 receptor agonist treatment in type 2 diabetes (T2DM) reduce blood glucose and food intake. It has been suggested that these effects are partly mediated through central GLP-1 receptors (GLP-1Rs). The rodent and nonhuman primate hypothalamus show clear GLP-1R expression. However, a detailed description of GLP-1R expression in the human hypothalamus is lacking, and it is unknown whether this expression is altered in T2DM patients. OBJECTIVE The… CONTINUE READING
6 Citations
28 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 28 references

Glucagon-like peptide-1 receptor (GLP1-R) mRNA in the rat hypothalamus

  • PJ Shugrue, M Lane, I. Merchenthaler
  • Endocrinology
  • 1996
Highly Influential
9 Excerpts

Plasma levels of glucagonlike peptide 1 and markers of obesity among young and healthy adults

  • JG van der Stouwe, S Aeschbacher, P Krisai, T Schoen, P Meyre, J Todd
  • Clin Endocrinol (Oxf ) 2015 Apr
  • 2015
Highly Influential
4 Excerpts

Similar Papers

Loading similar papers…